Is AZN or MCD cheaper?

On trailing earnings, MCD is cheaper: AZN trades at a 26.92 P/E and MCD at 23.48.

Which has grown faster, AZN or MCD?

Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus MCD at 6.95%.

Does AZN or MCD pay a bigger dividend?

AZN yields 1.79% and MCD yields 2.58% based on trailing dividends and the latest price.

Is AZN or MCD more profitable?

MCD runs the higher net margin — AZN at 17.19% versus MCD at 31.62%.

Which has been the better investment, AZN or MCD?

Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus MCD at 11.47%. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs McDonald's Corporation (MCD)

AZN leads on 10 of 16 compared metrics, though MCD is the cheaper stock.

A side-by-side comparison of AstraZeneca PLC and McDonald's Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

McDonald's Corporation

$202.36B

$284.81Consumer Cyclical

Total return — AZN vs MCD

growth of $100 · last 30y

AZN +732.9%MCD +1112.0%MCD compounded faster

AZN MCD

AZN vs MCD: by the numbers

•AZN is the larger company ($277.22B vs $202.36B market cap).
•MCD trades at the lower earnings multiple (23.48 vs 26.92 P/E).
•MCD converts more revenue to profit (31.62% vs 17.19% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 6.95% CAGR).
•MCD pays the higher dividend yield (2.58% vs 1.79%).

Which is better, AZN or MCD?

Metric tally: AZN 10 · MCD 6

It depends on what you're optimizing for:

ValueMCD(lower P/E)

GrowthAZN(faster 5Y revenue CAGR)

IncomeMCD(higher dividend yield)

QualityMCD(higher ROIC)

Metrics side by side

Valuation

Metric	AZN	MCD
P/E ratio	26.92	23.48●
Forward P/E	15.33●	20.07
P/S ratio	4.62●	7.40
P/B ratio	5.90	—
PEG ratio	0.14●	5.30
EV / EBITDA	14.92●	17.22
FCF yield	2.89%	3.46%●

Profitability

Metric	AZN	MCD
Gross margin	81.68%●	57.35%
Operating margin	23.69%	46.01%●
Net margin	17.19%	31.62%●
ROE	21.95%●	-478.38%
ROIC	13.03%	17.44%●

Dividends

Metric	AZN	MCD
Dividend yield	1.79%	2.58%●
Payout ratio	48.48%	61.25%

Growth (annualized)

Metric	AZN	MCD
Revenue CAGR (5Y)	16.99%●	6.95%
EPS CAGR (5Y)	22.02%●	13.58%
FCF CAGR (5Y)	15.68%●	5.78%
Total return CAGR (5Y)	11.03%●	6.16%

Frequently asked

Which is better, AZN or MCD?: It depends on your goal. value: MCD (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: MCD (higher dividend yield); quality: MCD (higher ROIC). Across all compared metrics, AZN leads 10 to 6.
Is AZN or MCD cheaper?: On trailing earnings, MCD is cheaper: AZN trades at a 26.92 P/E and MCD at 23.48.
Which has grown faster, AZN or MCD?: Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus MCD at 6.95%.
Does AZN or MCD pay a bigger dividend?: AZN yields 1.79% and MCD yields 2.58% based on trailing dividends and the latest price.
Is AZN or MCD more profitable?: MCD runs the higher net margin — AZN at 17.19% versus MCD at 31.62%.
Which has been the better investment, AZN or MCD?: Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus MCD at 11.47%. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full MCD analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio McDonald's P/E ratio AstraZeneca dividend yield McDonald's dividend yield AstraZeneca ROE McDonald's ROE AstraZeneca operating margin McDonald's operating margin AstraZeneca revenue growth McDonald's revenue growth AstraZeneca free cash flow McDonald's free cash flow

AstraZeneca & McDonald's appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Fastest Revenue Growth Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.